Antibiotice S.A. Logo

Antibiotice S.A.

ATB | RO

Overview

Corporate Details

ISIN(s):
ROATBIACNOR9
LEI:
315700P5G4O1L6GLMS02
Country:
Romania
Address:
VALEA LUPULUI, 707410 IAȘI
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Antibiotice S.A. is a Romanian pharmaceutical company specializing in the research, development, and manufacturing of generic drugs. The company operates eight GMP-certified manufacturing lines, producing a portfolio that includes sterile injectable products and active pharmaceutical ingredients (APIs). It holds U.S. Food and Drug Administration (FDA) approval for key products such as Ampicillin, Nafcillin, and the API Nystatin, demonstrating its commitment to international quality standards. Guided by a mission to make valuable medicines accessible and affordable, Antibiotice serves patients, physicians, and pharmacists in domestic and international markets.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Antibiotice S.A.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-04 12:29
Notice of Dividend Amount
Plata dividend - RC17
Romanian 2.1 MB
2025-08-13 12:27
Pre-Annual General Meeting Information
Convocarea adunarii generale a actionarilor - RC11
Romanian 1.4 MB
2025-08-06 12:40
Report Publication Announcement
Raport curent de informare a investitorilor
Romanian 137.7 KB
2025-07-24 12:07
Pre-Annual General Meeting Information
Convocarea adunarii generale a actionarilor - RC11
Romanian 1.6 MB
2025-07-09 12:28
Board/Management Information
Raport curent de informare a investitorilor
Romanian 491.4 KB
2025-07-01 11:49
Post-Annual General Meeting Information
Raport curent de informare a investitorilor
Romanian 606.7 KB
2025-06-20 14:01
Board/Management Information
Raport curent de informare a investitorilor
Romanian 168.7 KB
2025-06-05 11:06
Regulatory News Service
Raport curent de informare a investitorilor
Romanian 752.7 KB
2025-05-27 15:21
Pre-Annual General Meeting Information
Convocarea adunarii generale a actionarilor - RC11
Romanian 1.4 MB
2025-05-26 12:34
Post-Annual General Meeting Information
Raport curent de informare a investitorilor
Romanian 1.4 MB
2025-05-15 12:05
Post-Annual General Meeting Information
Raport curent de informare a investitorilor
Romanian 749.5 KB
2025-04-23 11:35
Pre-Annual General Meeting Information
Convocarea adunarii generale a actionarilor - RC11
Romanian 1.6 MB
2025-04-22 15:11
Pre-Annual General Meeting Information
Raport curent de informare a investitorilor
Romanian 3.9 MB
2025-03-13 07:54
Notice of Dividend Amount
Raport curent de informare a investitorilor
Romanian 688.4 KB
2025-03-13 07:50
Pre-Annual General Meeting Information
Convocarea adunarii generale a actionarilor - RC11
Romanian 1.4 MB

Automate Your Workflow. Get a real-time feed of all Antibiotice S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Antibiotice S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Bulgaria PHRM
Pharming Group N.V. Logo
Develops & commercializes protein & precision medicines for rare, life-threatening diseases.
Netherlands PHARM
Pharmocann Global Ltd. Logo
Develops, cultivates, and distributes pharmaceutical-grade medical cannabis products like oils/tablets.
Israel PMCN-M
Photocure ASA Logo
Develops photodynamic tech that makes bladder cancer cells glow for improved detection.
Norway PHO
Pierrel Logo
Global pharma firm making dental anesthetics & offering contract manufacturing services.
Italy PRL
Pluri Inc. Logo
Develops placenta-based cell therapeutics using a proprietary 3D cell-expansion platform.
Israel PLUR
PolyPeptide Group AG Logo
A global CDMO specializing in peptide and oligonucleotide APIs for pharma and biotech partners.
Switzerland PPGN
PZ Cormay S.A. Logo
Manufactures and distributes IVD reagents and analyzers for human and veterinary medicine.
Poland CRM
RaQualia Pharma Inc. Logo Japan 4579
Recordati Industria Chimica e Farmaceutica Logo
Develops, manufactures, and sells drugs for common and rare diseases and APIs globally.
Italy REC